Five Inspirational Non-Fiction Books by Physician-Writers You Won’t Want To Put Down

  1. Becoming Dr. Q: My Journey from Migrant Farm Worker to Brain Surgeon



In this spellbinding memoir, Dr. Q, short for Alfredo Quinones-Hinojosa, reveals his tumultuous, yet exciting journey, from his impoverished childhood in Mexico, to literally jumping the fence to enter the United States, to farming tomatoes for pennies under the unforgiving California sun, while also taking evening English classes, to graduating from Harvard Medical School, and finally becoming an internationally celebrated neurosurgeon and cancer researcher at the Johns Hopkins University. Dr. Q’s descriptions of his brushes with death are both gripping and uplifting, and his life is the American Dream personified.

  1. The Emperor of All Maladies: A Biography of Cancer


Dr. Siddhartha Mukherjee elegantly and effortlessly breaks it down for his readers, connecting the present with the past of cancer origins and the evolution of its treatment. Thorough, yet succinct, Dr. Mukherjee’s writing recounts the key events and figures that fundamentally changed the way we look at cancer today. After reading this biography of cancer, you will come out feeling educated and optimistic. A must read for anyone curious about the past, present, and future of this age-old disease.

  1. Mountains Beyond Mountains


Although not exactly written by a Physician-Writer, the book covers the life of an amazing and inspiring infectious disease specialist, Dr. Paul Famer, who is also a professor of medical anthropology at Harvard and the recipient of the MacArthur Genius Grant. In this biography of Dr. Farmer, author Tracy Kidder takes the reader to Haiti, where Dr. Farmer is literally working day and night to treat patients in a remotely-situated Haitian village. The book highlights Farmer’s unyielding efforts to improve the health of marginalized people, culminating in the founding of Partners in Health, in collaboration with his long time friend, Jim Yong Kim, who recently served as the president of the World Bank. By following Farmer around, Kidder captures how on more than one occasion, Farmer puts his patients’ needs before his own health, money, family, safety and even life. Kidder’s Mountains Beyond Mountains highlights the best humanity has to offer. A great read for anyone looking to feel motivated and inspired.

  1. Gifted Hands


Is the autobiography of the renowned Dr. Benjamin Carson, the first neurosurgeon in the world to successfully separate conjoined twins. A gripping narration of personal and professional challenges, the autobiography illustrates the victory of hard-work and determination over the many hurdles of poverty and discrimination that Dr. Carson faced as an African American child, growing up in a disadvantaged neighborhood of Detriot, Michigan, or even as a doctor, having his credibility repeatedly questioned by colleagues and patients alike. As a bonus, Dr. Carson skillfully describes several groundbreaking surgeries he pioneered in his fertile career as a neurosurgeon.

  1. When the Air Hits the Brain


This riveting memoir by Dr. Frank Vertosick Jr. presents some of the most challenging cases of his medical career as a neurosurgeon. Dr. Vertosick consciously chooses to narrate the cases with rather unhappy endings and contends that one learns more from failures than from successes, especially in surgery. The book is often recommended for medical students, but is also relevant to anyone interested in learning how doctors make some very difficult, life or death choices.



Two new studies on oral bacterium that causes lethal heart valve infection

Originally published in (ASBMB Today)

S. sanguinis
False-colored transmission electron micrograph of Streptococcus sanguinis cells (purple ovals) encased within an infected heart valve in an animal model of infective endocarditis. Mutants lacking either the NrdEF ribonucleotide reductase or the NrdI protein required for manganese cofactor formation were unable to cause disease. Click on the image to see a larger version of it.

Two back-to-back studies published in The Journal of Biological Chemistry have provided significant insights into virulence of Streptococcus sanguinis, which causes a potentially lethal infection of heart valves.

Infective endocarditis occurs when the otherwise innocuous S. sanguinis, a Gram-positive, facultative aerobic, oral bacterium, enters the blood stream and colonizes vulnerable heart valves or endocardial tissue, an infection that proves to be lethal for more than 20 percent of patients. The severity of this disease and the lack of a vaccine for it make it imperative to understand the mechanism of virulence by S. sanguinis to facilitate the development of potent antimicrobial agents.

The studies in the JBC resulted from a collaboration between the labs led by Todd Kitten at Virginia Commonwealth University and JoAnne Stubbe at the Massachusetts Institute of Technology.

Two past observations prompted the research teams to examine the activity of the bacterium’s class Ib ribonucleotide reductase, or RNR. These essential enzymes rely on metallo-cofactors to convert ribonucleotides into deoxyribonucleotides, precursors for DNA replication and repair. In S. sanguinis, RNRs occur in two forms: the aerobic class Ib and the anaerobic class III.

The first observation was that deletion of a manganese transporter called SsaB drastically reduces the virulence of S. sanguinis and its ability to tolerate oxygen. So the researchers set out to “identify manganese-requiring proteins that would also be required for growth in oxygen,” explains Kitten. The second observation was that class Ib RNRs, along with an iron cofactor, also appear to employ a dimanganese-tyrosyl radical cofactor for in-vivo activity. “We wondered whether the oxygen-dependent class Ib RNR might be the manganese-requiring enzyme we were seeking,” Kitten says.

In the first study, the researchers demonstrated that the S. sanguinis RNR can not only self-assemble a diferric-tyrosyl radical in the presence of oxygen, but also assemble a dimanganese-tyrosyl radical, if provided with an additional enzyme called NrdI.

Todd Kitten
Joanne Stubbe

“In my view, the main contribution of the first study was that it identified all the components and established that the S. sanguinis RNR had the properties that were expected of it,” says Kitten. “We confirmed that RNRs behaved the way we thought they would in vitro, and we provided direct evidence about which components are required for RNR activity.”

Emboldened by those findings, the researchers in the second study created mutant strains of S. sanguinis lacking class Ib RNR or other RNR-related enzymes and tested those mutants for growth competency under aerobic and anaerobic conditions.

The authors reported that the mutants lacking the genes for synthesis of class Ib RNRs or the manganese cofactor were unable to grow aerobically (but grew normally under anaerobic conditions) or cause endocarditis in a rabbit model system. This phenotype, however, could be partially rescued by heterologous complementation with a class II RNR gene, which codes for an oxygen-independent, adenosylcobalamin-cofactored RNR.

These results allowed the authors to conclude that manganese was indeed critical for the proper function of RNRs and, consequently, for the virulence of S. sanguinis.

The work is significant because the results provide a novel target — manganese cofactored RNRs — for developing antimicrobial agents designed to treat infective endocarditis, and that is made even more promising by the fact that such RNRs do not exist in eukaryotes. The results also may answer the longstanding question of why some bacteria require manganese for oxygen tolerance and virulence.


Nature’s Tea Lights: How Bioluminescent Organisms are Brightening Our Present and Our Future

It is summer time again and nature’s little tea lights-the fireflies- can be spotted everywhere. Many of us have fond memories of collecting them in a jar to make a lantern and awing at their glow.

Bioluminescent organisms produce light as a result of a reaction of a specific chemical with oxygen in the presence of a dedicated molecular catalyst, or enzyme. A vast variety of organisms exhibit this phenomenon, including insects, flies, fungi, snails, worms, and even microorganisms like dinoflagellates and bacteria. While many of these organisms can be found on land, most live in the ocean, where in the deep, dark waters, a little light can take them quite far. These incredible animals use their light to attract mates, communicate danger or other signals to their kin, startle, intimidate, and even fight predators.

Through decades of research on this fascinating phenomenon, scientists have achieved an impressive understanding of the key players involved in the production of light in a variety of bioluminescent organisms. The generated knowledge is now being applied to solve rather complex challenges facing biomedical research aimed at drug discovery as well as the development and treatment of cancer.

The application is called bioluminescence imaging (BLI), and is based on a simple idea: Use recombinant DNA technology to produce target cells expressing bioluminescence-effecting enzymes, provide the chemical substrate, and track target cells in a live animal by imaging the production of light.

The uses of this non-invasive technology are innumerable. For example, human brain tumor cells can be genetically modified to express firefly luciferase, the enzyme responsible for catalyzing the production of light by luciferin (the chemical), transplanted into mice brain, and visualized using a specialized camera upon deliverance of luciferin. The resulting light signals the presence of tumor cells. Using this study design, scientists can assess the effect of various chemotherapy drugs on the size of the tumor, and determine parameters such as dosage and efficacy of the drugs, and the time a particular drug takes to stall a neoplastic growth.

BLI is also tackling metastasis, or the spread of cancer from one part of the body to the other. Luciferase-expressing tumor cells can be injected in the tail veins of mice and their migration tracked by following the emission of light from the body of the mice. Another exciting avenue is exploiting the ability of bacteria to preferentially colonize tumor cells by injecting specially engineered bioluminescent bacteria into mice models of cancer to track the presence of cancerous lesions in the mice. Scientists hope that these bacteria can be engineered to serve as targeted drug delivery vehicles to the site of cancer lesions, to prevent damage to bystander cells, as is often the side-effect of chemotherapy. Other areas of application include “cell signaling, transcriptional promoters, gene expression, protein-protein interactions” and many more.

As with any technology, BLI has its limitations and drawbacks. Thus, efforts are being made every day to improve the technology by engineering enzymes with longer half-lives and better stability, more sensitive detection methods, and efficient experimentation techniques.

One of the basic challenges with biomedical research is differentiating a cell or tissue of interest from the rest. Visualization offers a viable solution. Being able to differentially visualize the cell or tissue of interest can allow one to make targeted interventions. It’s like walking in a room and having a specific switch to only turn on the light of a lamp in one of the many rooms with many lamps of a mansion- a complex task, simplified elegantly by the promise of BLI.


Works Cited:

Ruxana T. Sadikot and Timothy S. Blackwell. Bioluminescent Imaging. Proc Am Thorac Soc. Dec 2005; 2(6): 537–540.

Badr CE. Bioluminescence Imaging: Basics and Practical Limitations. Methods Mol Biol. 2014;1098:1-18

Haddock SHMoline MACase JF. Bioluminescence in the Sea. Ann Rev Mar Sci. 2010;2:443-93

Haddock, S.H.D.; McDougall, C.M.; Case, J.F. “The Bioluminescence Web Page”, (created 1997; updated 2011; accessed 06/27/14).

Exquisite Scientific Art at Dulles International Airport

Image of a brain showing hallmarks of Alzheimer's disease by Alvin Gogineni, Genentech

Image of a brain showing hallmarks of Alzheimer’s disease (blue) by Alvin Gogineni, Genentech

I had just landed at the Dulles International Airport after flying non-stop for five hours from the Pacific to the Eastern Time zone, with a fussy toddler in my lap. It was two in the morning. Tired, hungry, and hauling about five different types of luggage, including a Hummer of a stroller, I was not feeling particularly up beat.

Yet, as I walked through the brightly lit passage on my way to the baggage claim, I was pleasantly struck by the sight of something very familiar adorning the otherwise bare walls- exquisite backlit microscopic images of biological cells and tissues.  Suddenly, I was at an art gallery, except that the images were authentic scientific data produced as a result of cutting edge biomedical research by scientists all over. Awe-inspiring pictures capturing the dynamic biological world, not visible to the naked eye, of mitotic cells with dividing DNA, viruses, the brain tissue and bacteria made me stop and take a look.

Life: Magnified,” is a result of a collaboration between the NIH’s Institute of General Medical Sciences, the American Society for Cell Biology, and the Metropolitan Washington Airports Authority’s Arts Program, and entails a display of 46 eclectic photographs selected from over 600 submissions by prominent researchers.

These images up till now have mostly been exclusive, often appearing in scientific journals or conferences, not readily accessible to laymen. By displaying the images at a venue which sees millions of passengers every year, the airport is contributing to the important task of increasing public awareness of the strides made everyday by researchers in solving the big questions facing us, including discovering cures to devastating diseases. Moreover, the images will inspire curious individuals to enter the world of scientific research. But most importantly, they provide a much-needed boost to fatigued travelers by reminding them of the beauty in the tiny things that surround us.


What’s the point of art?

If I ever win the lottery, I will fill my place with classic paintings by my favorite artists-Rembrandt, Vermeer, Monet, Titian- a dreamy aspiration shared by many around the globe. A fortunate few, and I mean both figuratively and literally, are actually able to realize this dream. In fact, some of the world’s most valuable art is owned by such moguls, like the famous Paul Cézanne painting The Card Players, sold to the Royal Family of Qatar at a jaw-dropping cost of $250 million to $300 million, or artist Willem Kooning’s Woman III, purchased by the American Hedge Fund manager, Steven Cohen, for an astounding $137.5 million, or Francis Bacon’s Triptych, bought by the Russian billionaire Roman Abramovich for $86.4 million. Even the fictional magnate Gail Wynard from The Fountainhead had his very own walk-in gallery of exquisite art right in his home- his authentic refuge from an artificial world.

Aside from the obvious monetary and investment values of these paintings, there is a more intangible value to art, almost spiritual in nature that unites us all. People from all socio-economic backgrounds, ages, nationalities, spend hours appreciating, creating, buying, discussing, and promoting art. Governments dedicate time and resources on setting up departments of art and culture, aimed at promoting and protecting art (sadly even destroying art incompatible with their ideologies). In fact, some of a child’s first modes of communication include not words, but art in the form of colors, drawings, objects, songs. Moreover, studying art alone can potentially reveal the entire history and evolution of mankind; from the first cave paintings in Spain etched on rock 40,000 years ago, to Rembrandt’s Anatomy lesson of Dr. Nicolaes Tulp from 1632, to the contemporary Obama murals by anonymous artists, adorning the dilapidated walls of Brooklyn.

Could the experience of looking at art be similar to meditation? A chance to be alone with your mind, a moment for introspection, to focus on just one thing—not on the echoing of Om– but on the vivid colors and textures of a painting, or the intricate carvings on a delicate porcelain vase– and channel your senses in a single direction to experience one’s own version of peace, love, or pleasure. Several scientific studies have used modern techniques such as functional magnetic resonance imaging (fMRI) (a technique that measures brain activity based on corresponding changes in blood flow) of the brain to reveal temporary and permanent effects from meditation on the brain. Do similar effects occur through thorough imbuement of the brain by art?

Other scientifically interesting questions arising from this prevalent and timeless phenomenon of art are: How does the brain process art? What about art gives us pleasure worth spending our limited time and money? In short, why do we, as a species, look at art? Is it because other, seemingly knowledgeable experts tell us that it’s something worth looking at? Would Van Gogh’s vase of twelve sunflowers be just an ordinary painting if it didn’t come with the brand name? Or do we just like looking at beautiful things (although plenty of famous art isn’t exactly beautiful)?

This fundamental human behavior has given rise to a burgeoning discipline of neuroscience: neuroaesthetics: a discipline dedicated to understanding the neurological basis of aesthetic experiences,

Using modern techniques and tools, scientists are working to understand why and how we look at art. For example, fMRI techniques can be used to determine the ways our brain activity changes in response to looking at art. Van Gogh’s paintings, as one study shows, activate the MT+ region of the brain (responsible for deciphering object locations), evoking a sense of movement in the viewer. Another study reveals that facial portraits activate a different region of the brain, when compared to landscape paintings. Moreover, beautiful faces activate the fusiform face region (responsible for facial recognition) and its adjacent areas, a neural activity that seems to increase with the beauty of an art piece*.

Neuroaesthetics studies have also provided insights into factors that influence our perception of art. For example, when labeled as belonging to a museum, an art piece receives better rating by its viewers, and greater neural activity is observed in certain areas of their brains. Moreover, different areas of the brain are activated in response to viewing an original masterpiece, or a copy* .

Another intriguing area of investigation is understanding the paradox of how certain neurological diseases enhance the artistic capabilities of patients, often allowing them to produce “realistic, obsessive, and detailed” art. Interestingly, some autistic individuals, given their characteristic obsessive-compulsive traits, are also predisposed to producing amazing art*.

It seems that when it comes to appreciating art, or even producing it, we rely on a combination of our built-in biology, as well as the experiences and environmental cues that influence our everyday experiences from the moment we are born. Thus, understanding why we look at art, can potentially enhance our understanding of complex concepts concerning human behavior, such as “mate selection, consumer behavior, and communication*.” Because even a mere still life can set into motion a surge of activity in the intricate neural circuitry of our complex brains.

*Chatterjee and Vartanian (2014) Trends in Cognitive Science


Facing recession in early adulthood can prevent narcissism later in life

Finding a job is a humbling experience. As I go through the motions of a job search-applying, interviewing, networking- I find myself, inadvertently riding a roller coaster, precariously seated on the tracks of fickle emotions-confidence, self-doubt, poise, jubilation, and desperation.  Fortunately, once in a while,  I get a bolstering call or an email that offers me a positive direction or a much-needed nudge to stay strong to realize my unconventional career goals and interests.

In an economic recession, however, such a nudge is infrequent, or even non-existent, and the hardest hit are the young adults entering the workforce for the first time. A dearth of jobs enables employers to be selective and to only extend offers to highly skilled and experienced individuals, leaving young adults with limited to zero choices. The experience has a long-lasting effect on the psychology of these impressionable individuals, according to the results of a recent study by Emily Binachi at the Emory University.

Binachi started out by asking a reasonable question. “Does entering adulthood during a recession affect how narcissistic a person ultimately becomes? Narcissists regard themselves as superior to other people and believe that they are entitled to good outcomes, excessive admiration, and unyielding praise.”

To answer her question, Binachi surveyed thousands of individuals, asking them a variety of questions aimed at scientifically quantifying their level of narcissism, self-esteem, and economic conditions in emerging adulthood.

Binachi found that “entering adulthood during a recession tempered narcissism later in life, ” and the affected individuals were less likely to feel superior or entitled, related to others. Binachi also found that higher unemployment rates during emerging adulthood were associated with lower narcissism scores later in life, while economic conditions in the subsequent period were not as predictive of current narcissism. Most interesting was Binachi’s finding that CEOs of various companies who came of age in economic recessions paid themselves relatively less than those who entered adulthood in more prosperous times.

The results of Binachi’s studies offer a plausible explanation for the presence of narcissism in certain individuals. Other identified sources of such behavior include overindulgent and overprotective parenting and excessive and unearned praise during childhood. Personally, her study offers me a fresh perspective on my own job search- an opportunity in character building!



MERS- a new disease from the old world

After the 2003 SARS epidemic claimed almost a thousand lives worldwide, another coronavirus is now rearing its ugly head from the Arabian Peninsula. The etiological agent of the Middle East Respiratory Syndrome (MERS), MERS-CoV is thought to arise from an animal source, possibly camels (or bats). How exactly the virus has managed to jump from animal species to humans to be transmitted from person-person is still a mystery, but possible routes include intake of unpasteurized, contaminated camel milk or meat.


MERS is characterized by non-specific symptoms such as fever, shortness of breath, and cough, and is associated with an alarming mortality rate of 30%. Treatment includes alleviating symptoms and isolating the patient to prevent transmission. Other aspects of the infection that are of concern include the lack of a vaccine or specific treatment for the disease; an alarming spike in the number of cases since the diagnosis of the first human case in 2012; and the possibility of rapid global spread from international travel.


Recently, the Centers for Disease Control (CDC) issued a statement regarding MERS after a traveler contracted the disease in Saudi Arabia. In the statement, CDC has advised Americans to protect themselves by frequently washing hands, avoiding close contact with people who are sick, avoid touching their eyes, nose, and/or their mouths, and disinfecting frequently touched surfaces.  Although the CDC does not recommend anyone to change their travel plans to the Middle East, it does stress seeking immediate medical attention when experiencing symptoms such as shortness of breath, fever, and cough within 14 days of travel to the Middle East.


The good news is that several lessons derived from dealing with the SARS pandemic in 2003 may help nip this nascent uprising in the bud. These include checking travelers for indicators of fever, quarantine of patients, as well as increasing awareness on behaviors to prevent contracting the virus. Moreover, the CDC is working closely with the World Health Organization to understand the virus, trace its source, as well as quickly develop an appropriate drug or vaccine against it.



Public-private initiative aims to speed drug development for three illnesses

(originally published in ASBMB Today )

It takes several years and millions of dollars for a new drug to come to market, starting from the time that its properties are first studied at the bench. That’s a lot of time and money. What’s even more stupefying is that only a fraction of drug candidates make it to market. Clearly, a new approach to drug development is needed — one that not only expedites and increases the availability of drugs but also maintains the high standard of quality needed to ensure safety and efficiency.

A new collaboration announced earlier this year called the Accelerating Medicines Partnership seems to promise a viable solution. The collaborators include 10 of the world’s leading pharmaceutical companies, the National Institutes of Health and several nonprofits. The goal: to develop new treatments earlier for three serious conditions — Alzheimer’s disease, type 2 diabetes and autoimmune disorders, namely rheumatoid arthritis and lupus.

Participants in Accelerating Medicines Partnership

“Patients and their caregivers are relying on science to find better and faster ways to detect and treat disease and improve their quality of life,” NIH Director  Francis S. Collins said in the announcement.

The syndicate has pledged more than $230 million over the next five years for research aimed at identifying biological targets and characterizing new biomarkers. The parties have agreed unanimously to make the resulting data and analyses publicly available despite conventionally being competitors. The expected consequence is the stitching together of a vast knowledge network needed to solve the big problems of pharmaceutical research.

 Mikael Dolsten, president of worldwide research and development at Pfizer, a participant of AMP, optimistically prognosticated that “this type of novel collaboration will leverage the strengths of both industry and NIH to ensure we expedite translation of scientific knowledge into next-generation therapies to address the urgent needs” of patients.

The research will be overseen by steering committees with representation from both the public and private sectors. Offering even more hope to patients and families is the possibility of extending AMP to other diseases and conditions through advances made by the milestone-driven pilot projects in the three disease areas.

Capturing the spirit of the collaboration, Rupert Vessey of Merck said, “Our most critical health challenges require new, innovative ways to develop medicines and vaccines. Collaborations such as this, that exchange data, share insights and generate knowledge, will be important to unraveling the mysteries of the diseases that cause suffering for individuals and are a burden to our society.”


Electronic cigarettes just blowing smoke?

A new study has determined that the use of electronic cigarettes does not correlate to smoking cessation. In the longitudinal study, researchers analyzed data from 949 American smokers and concluded that e-cigarette users were not more likely to quit or reduce smoking, when compared to non-users.

E-cigarettes have been widely promoted as effective tools for helping smokers quit cigarettes. The results of this study bring to question the authenticity of those claims. Moreover, concerns are being raised about the effects on health of the constituents of e-cigarettes.

Regardless, new tools designed to enable smoking cessation are needed.  More and more research is elucidating the dangers of cigarette smoke to bystanders. Work by Bo Hang and group at University of California reveals that third hand smoke, residual smoke that gets absorbed by walls and furniture in a house, can be extremely dangerous. Third hand smoke can react with indoor air pollutants such as ozone and nitrous acid and produce carcinogenic compounds, which bind to DNA and lead to cancer. Moreover, according to a study published in Lancet, banning cigarettes in public places is associated with a reduction in premature births and childhood asthma in the US and in Europe. Thus, second-hand smoke is detrimental to the health of pregnant women, newborn babies and children.

Cigarette smoking is the leading cause of cancer in the United States, and accounts for 30% of all cancer deaths. According to the Center for Disease Control, about 1 in 5 of all adults in the country is a smoker. With such an epidemic at hand, a range of arsenal must be employed to smoke out cigarettes.



“You, me, everyone- we are made of star stuff”- A look at Cosmos: A Spacetime Odyssey

Through a peculiar collaboration between Seth MacFarlane, creator of the notoriously controversial, nonsensical, yet widely popular TV shows, Family Guy and American Dad, and Ann Druyan, wife of one of the most prominent science communicators of the 20th century, the late Carl Sagan, with whom she co-wrote the immensely popular PBS documentary Cosmos, comes Cosmos: A Spacetime Odyssey– a sequel to the original Cosmos series.

The series premiered on March 9, 2014, on FOX and The National Geographic Channel. After watching the first two episodes, I can confidently say that the show is truly a treat for the imagination. Renowned astrophysicist Neil deGrasse Tyson takes the viewer on a fascinating journey free from the limits of time and space on the Ship of Imagination. Tyson communicates complex concepts of the Big Bang Theory, Evolution, Speciation, Artificial and Natural Selection with ease and simplicity. The enchanting soundtrack by Alan Sylvestri, together with Tyson’s scintillating narration, creates a magical and transcendental experience for the viewer. Enhancing the experience further are the convincing animations by Kara Vallow, known best for her work in quite contrasting shows such as (again!) Family Guy and The Cleveland Show.

Some striking images from the show include Jupiter’s Great Red Spot, characterized by a monstrous hurricane three times the size of earth; Voyager 1, traversing through space, waiting to be discovered by extraterrestrial intelligent life; macromolecular structures called Kinesins, diligently carrying cargo along microtubules inside an eukaryotic cell; and the lakes and rivers of liquid methane and ethane flowing through mountains of ice on the surface of Titan, the largest moon of Saturn.

A distinct feature of the first episode is Tyson’s seamless compression of the 13.8 billion years of the universe onto The Cosmic Calendar, in which every month is represented by approximately a billion years. Starting with The Big Bang on January 1, to the inception of life on earth on September 1, to the venture of Tiktaalik from sea to land on November 17, to the impact of an asteroid hitting the earth and effecting the extinction of dinosaurs on December 30, and finally to the evolution of humans, happening only on the last hour of the last day of the cosmic calendar, Tyson effectively provides an orientation to the dynamic and rather volatile universe we call home.

For discovering the mind-bogglingly vast cosmos, Tyson stipulates willingness to “test ideas by experiment and observation, build on ideas that pass the test, reject the ones that fail, follow the evidence wherever it leads and question everything. Accept these terms and the cosmos is yours!”

The show will feature thirteen episodes broadcasted to 37 different countries. It promises to offer profound insights, derived from the latest scientific evidence, into the origin of life and the future of our planet and our universe. So, stay tuned!